SCHEMBL7716783

SCHEMBL7716783

N#Cc1cc(F)ccc1N1CCC(NCCN)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.45
MTOR P42345 2/20 0.42
RPTOR Q8N122 2/20 0.42
MLST8 Q9BVC4 2/20 0.42
DPP4 P27487 4/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
FFAR4 Q5NUL3 1/20 0.39
OPRL1 P41146 3/20 0.38
USP30 Q70CQ3 2/20 0.37
GRM2 Q14416 1/20 0.36
KDM4E B2RXH2 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
BACE1 P56817 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
VCP P55072 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150022 0.88 HTR1D (0.48) CHRM4MTORRPTORMLST8DPP4
SCHEMBL7715928 0.85 FFAR4 (0.39) MTORRPTORMLST8FFAR4
SCHEMBL7715960 0.84 CHRM4 (0.46) CHRM4DPP4DPP8DPP9KDM4E
SCHEMBL7716779 0.82 CHRM4 (0.47) CHRM4MTORRPTORMLST8DPP4
SCHEMBL7714987 0.82 KDM4E (0.44) CHRM4KDM4EDRD2DRD3
SCHEMBL8221478 0.80 CHRM4 (0.48) CHRM4MTORRPTORMLST8DPP4
SCHEMBL7714679 0.78 CHRM4 (0.49) CHRM4MTORRPTORMLST8DPP4
SCHEMBL21360337 0.78 CHRM4 (0.43) CHRM4DPP4FFAR4
Hydrochloric Acid SCHEMBL20141131 0.77 HTT (0.43) CHRM4DPP4FFAR4KDM4E
SCHEMBL20141678 0.76 CHRM4 (0.50) CHRM4MTORRPTORMLST8DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376503-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC 2002-04-23 US disclosed
EP-1023068-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-05-16 EP disclosed
EP-1023068-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-08-02 EP disclosed
WO-1998057638-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed